Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Non-Current Liabilities (2018 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Other Non-Current Liabilities over the past 13 years, most recently at $9.7 million for Q2 2025.

  • Quarterly results put Other Non-Current Liabilities at $9.7 million for Q2 2025, down 19.24% from a year ago — trailing twelve months through May 2025 was $9.7 million (down 19.24% YoY), and the annual figure for FY2025 was $9.7 million, down 19.24%.
  • Other Non-Current Liabilities for Q2 2025 was $9.7 million at Lifecore Biomedical, Inc. \De\, down from $23.9 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for LFCR hit a ceiling of $64.9 million in Q2 2023 and a floor of $183000.0 in Q4 2023.
  • Median Other Non-Current Liabilities over the past 5 years was $2.6 million (2021), compared with a mean of $10.7 million.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 93.38% in 2022 and later soared 34057.89% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Other Non-Current Liabilities stood at $1.9 million in 2021, then tumbled by 89.6% to $201000.0 in 2022, then fell by 8.96% to $183000.0 in 2023, then skyrocketed by 12632.24% to $23.3 million in 2024, then plummeted by 58.19% to $9.7 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $9.7 million (Q2 2025), $23.9 million (Q1 2025), and $23.3 million (Q4 2024) per Business Quant data.